Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy
CG Campion, O Sanchez-Ferras… - Canadian journal of …, 2017 - journals.sagepub.com
Purpose of review: Diabetic nephropathy (DN) is a progressive kidney disease caused by
alterations in kidney architecture and function, and constitutes one of the leading causes of …
alterations in kidney architecture and function, and constitutes one of the leading causes of …
[HTML][HTML] Biomarkers in diabetic nephropathy: present and future
G Currie, G McKay, C Delles - World journal of Diabetes, 2014 - ncbi.nlm.nih.gov
Diabetic nephropathy (DN) is the leading cause of end stage renal disease in the Western
world. Microalbuminuria (MA) is the earliest and most commonly used clinical index of DN …
world. Microalbuminuria (MA) is the earliest and most commonly used clinical index of DN …
Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic …
ME Pavkov, WC Knowler, RL Hanson… - American journal of …, 2013 - Elsevier
BACKGROUND: We compared values of baseline serum cystatin C (SCysC), serum
creatinine (SCr), and measured glomerular filtration rate (mGFR) for predicting end-stage …
creatinine (SCr), and measured glomerular filtration rate (mGFR) for predicting end-stage …
Cistatina C en la evaluación de la función renal
MF García, E Coll, SV Pedret, CB Guitarte… - Revista del laboratorio …, 2011 - Elsevier
La medición del filtrado glomerular es el mejor índice de valoración de la función renal. La
creatinina sérica es el marcador de filtrado glomerular más utilizado, a pesar de estar …
creatinina sérica es el marcador de filtrado glomerular más utilizado, a pesar de estar …
Influence of age, gender, smoking, diabetes, thyroid and cardiac dysfunctions on cystatin C biomarker
O Al Musaimi, AH Abu-Nawwas, D Al Shaer… - Medicina de Familia …, 2019 - Elsevier
Background Creatinine is the most widely used renal failure biomarker; however, it has a lot
of drawbacks. One of the major drawbacks is the blind range (does not increase until 50% of …
of drawbacks. One of the major drawbacks is the blind range (does not increase until 50% of …
Cystatin C and its role in patients with type 1 and type 2 diabetes mellitus
AM Bashier, AAS Fadlallah… - Advances in …, 2015 - Wiley Online Library
Diabetes mellitus is the commonest cause of CKD. It is the leading cause of new patients
requiring renal replacement therapy, accounting for 40%, 34%, and 30% of cases in United …
requiring renal replacement therapy, accounting for 40%, 34%, and 30% of cases in United …
[HTML][HTML] Chronic kidney disease screening methods and its implication for Malaysia: an in depth review
Y Almualm, HZ Huri - Global Journal of Health Science, 2015 - ncbi.nlm.nih.gov
Abstract Chronic Kidney Disease has become a public health problem, imposing heath,
social and human cost on societies worldwide. Chronic Kidney Disease remains …
social and human cost on societies worldwide. Chronic Kidney Disease remains …
Short‐Term High Fat Intake Does Not Significantly Alter Markers of Renal Function or Inflammation in Young Male Sprague‐Dawley Rats
C Crinigan, M Calhoun… - Journal of nutrition and …, 2015 - Wiley Online Library
Chronic high fat feeding is correlated with diabetes and kidney disease. However, the
impact of short‐term high fat diets (HFD) is not well‐understood. Six weeks of HFD result in …
impact of short‐term high fat diets (HFD) is not well‐understood. Six weeks of HFD result in …
Addition of tolvaptan compared with increased dose of furosemide in heart failure patients with chronic kidney disease under furosemide treatment
T Tanaka, S Minatoguchi, Y Yamada… - Circulation …, 2019 - jstage.jst.go.jp
Background: Given that residual congestion is a predictor of poor outcome in patients with
heart failure (HF), a therapeutic strategy for decongestion is required. Methods and Results …
heart failure (HF), a therapeutic strategy for decongestion is required. Methods and Results …